This is way better thinking , I actually agree I would

New Post Public Reply Private Reply Replies (0) Message Board
reallypeople? CDiddy #55781
536
This is way better thinking , I actually agree


I would take $40 a share right now as well.

However, and Im hoping this brings all sides of this conversation together: There currently exists an amount of risk (we dont need to agree on the amount for this conversation).

If we get a PDUFA date, the amount of risk decreases. If we get an EUA authorization the amount of risk decreases. Revenue, partnerships, etc.

Point being that as we continue to de-risk, the share price will rise as will the amount necessary for a buy out.

I doubt that I would vote to approve $40 a share if we receive EUA and our share price rises to say $20/share.
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Innovative Green Technologies from Shanghai Electric Transform Energy Landscape

Updated Category News Views 295

Innovative Green Technologies from Shanghai Electric Transform Energy Landscape Shanghai Electric has remarkable aspirations for a sustainable and cleaner future. At a recent summit, the company proudly showcased its pioneering technologies geared towards green energy, including advancements in green hydrogen, sustainable formaldehyde production, photovoltaics,...

Continue Reading
Northview Residential REIT Declares August Cash Distribution

Updated Category News Views 163

Northview Residential REIT Announces Cash Distribution CALGARY, Alberta — Today, Northview Residential REIT, often recognized for its focus on quality real estate investments, made an important announcement regarding its August 2025 cash distribution amounts. This announcement showcases the REIT’s ongoing commitment to providing value to its investors. Details of the...

Continue Reading
Virpax Pharmaceuticals Sees Major Surge After Army Study Results

Updated Category News Views 203

Virpax Pharmaceuticals Experiences Remarkable Growth Virpax Pharmaceuticals, Inc. recently made headlines as their stock witnessed an impressive surge. This excitement primarily stems from the successful conclusion of a preclinical study that the U.S. Army's Institute of Surgical Research conducted. The study was part of a larger effort aimed at enhancing pain management...

Continue Reading
Boomi Celebrates Recognition as Top Workplace for Innovators

Updated Category News Views 39

Boomi recognized for building an innovative workplace Boomi™, the intelligent integration and automation leader, was named to Fast Company’s annual Best Workplaces for Innovators list. The honor underscores Boomi’s focus on creating a place where new ideas move freely, teams experiment, and that open exchange shows up in how customers are supported every day. How...

Continue Reading
Faruqi & Faruqi, LLP Investigates Marex Group Claims for Investors

Updated Category News Views 186

Faruqi & Faruqi, LLP Launches Investigation for Marex Group Investors Investors who have faced difficulties due to their investments in Marex Group plc are encouraged to reach out to Faruqi & Faruqi, LLP. The leading national securities law firm specializing in protecting investors' rights has begun a new investigation aimed at determining the merits of claims against the...

Continue Reading